IDH2 Gene Mutation: Clinical Trials

1 trial for IDH2 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Active not recruiting 1

Follow IDH2 Gene Mutation: new trials by email Literature Review of IDH2 Gene Mutation trials Research Report on IDH2 Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Niraparib In Recurrent IDH 1/2 Gliomas
Niraparib, Resection/Treatment with Niraparib - Low-grade Glioma, IDH2 Gene Mutation
Early Phase 1Active not recruitingMassachusetts General Hospital162023-05-182026-07-24

Narrower conditions

Glioma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Interventions

Therapeutics (1)  ·  niraparib (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

Isabel Arrillaga-Romany, MD, Phd (1)